Search Results - "Farag, Youssef M. K."

Refine Results
  1. 1

    Psoriasis and oral health in adult United States population: a cross-sectional study by Hussein, Mai, Farag, Youssef M K, Sonis, Stephen

    Published in BMC oral health (02-02-2023)
    “…To detect the association between psoriasis as an exposure and oral health conditions as outcomes represented by periodontal and dentition status. This was…”
    Get full text
    Journal Article
  2. 2

    Albuminuria: An Underappreciated Risk Factor for Cardiovascular Disease by Barzilay, Joshua I, Farag, Youssef M K, Durthaler, Jeffrey

    Published in Journal of the American Heart Association (16-01-2024)
    “…Albuminuria, an established biomarker of the progression of chronic kidney disease, is also recognized as a biomarker for the risk of cardiovascular disease…”
    Get full text
    Journal Article
  3. 3

    Vitamin D deficiency is independently associated with greater prevalence of erectile dysfunction: The National Health and Nutrition Examination Survey (NHANES) 2001–2004 by Farag, Youssef M.K, Guallar, Eliseo, Zhao, Di, Kalyani, Rita R, Blaha, Michael J, Feldman, David I, Martin, Seth S, Lutsey, Pamela L, Billups, Kevin L, Michos, Erin D

    Published in Atherosclerosis (01-09-2016)
    “…Abstract Background and aims Erectile dysfunction (ED) and atherosclerotic cardiovascular disease (ASCVD) share many common risk factors, and vascular ED is a…”
    Get full text
    Journal Article
  4. 4

    Serum vitamin D and sex hormones levels in men and women: The Multi-Ethnic Study of Atherosclerosis (MESA) by Zhao, Di, Ouyang, Pamela, de Boer, Ian H, Lutsey, Pamela L, Farag, Youssef M.K, Guallar, Eliseo, Siscovick, David S, Post, Wendy S, Kalyani, Rita R, Billups, Kevin L, Michos, Erin D

    Published in Maturitas (01-02-2017)
    “…Graphical abstract In a cross-sectional analysis of 3017 men and 2931 women in a multi-ethnic cohort, lower vitamin D levels [per 10 ng/ml (25 nmol/L) lower…”
    Get full text
    Journal Article
  5. 5

    Occupational risk factors for chronic kidney disease in Andhra Pradesh: 'Uddanam Nephropathy' by Farag, Youssef M. K., Karai Subramanian, Kuyilan, Singh, Vikrum A., Tatapudi, Ravi Raju, Singh, Ajay K.

    Published in Renal failure (01-01-2020)
    “…CKD of unknown etiology (CKDu) has been reported in several countries including India. We previously showed a prevalence of CKD in India to be 17.2% and we…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Kidney Pathological Changes in Metabolic Syndrome: A Cross-sectional Study by Alexander, Mariam P., MD, Patel, Tejas V., MD, Farag, Youssef M.K., MD, Florez, Adriana, MD, Rennke, Helmut G., MD, Singh, Ajay K., MBBS, MBA, FRCP

    Published in American journal of kidney diseases (01-05-2009)
    “…Background The worldwide prevalence of metabolic syndrome is increasing and has been associated with chronic kidney disease. Kidney pathological findings in…”
    Get full text
    Journal Article
  8. 8

    Metabolic and inflammatory biomarkers in children with atopic dermatitis (AD): a case-control study by Mohamed, Amal Ahmed, Salah, Eman Mohamed, Bedair, Nermeen Ibrahim, Bassiouny, Dina M., Daifalla, Aliaa E. M., Behairy, Ola G., Fawazy, Naglaa, Al Soda, Mohamed F., Farag, Youssef M. K.

    “…Background Atopic dermatitis is characterized by impaired skin barrier and altered cutaneous innate immunity. The estimated prevalence among Egyptian children…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients by Nangaku, Masaomi, Farag, Youssef M K, deGoma, Emil, Luo, Wenli, Vargo, Dennis, Khawaja, Zeeshan

    Published in Nephrology, dialysis, transplantation (28-07-2020)
    “…Vadadustat is an investigational, oral hypoxia-inducible factor prolyl hydroxylase inhibitor in development in Japan for the treatment of chronic kidney…”
    Get full text
    Journal Article
  11. 11

    Differential associations of rheumatoid arthritis and periodontitis or tooth loss: A cross‐sectional study by Hussein, Mai, Farag, Youssef M. K., Sonis, Stephen

    Published in Journal of clinical periodontology (01-03-2023)
    “…Aim To study the association between periodontitis, tooth loss, and rheumatoid arthritis (RA) by using a large national dataset. Materials and Methods An…”
    Get full text
    Journal Article
  12. 12

    Diabesity: an overview of a rising epidemic by Farag, Youssef M K, Gaballa, Mahmoud R

    Published in Nephrology, dialysis, transplantation (01-01-2011)
    “…'Diabesity' is the term for diabetes occurring in the context of obesity. In this review, we will overview the latest epidemiological data available describing…”
    Get full text
    Journal Article
  13. 13

    Impact of Preoperative Weight Loss on 30-Day Complication Rate after Bariatric Surgery by Saleh, Omnia S, Farag, Youssef Mk, Medhati, Pourya, Tavakkoli, Ali

    “…The aim of this study is to evaluate the impact of pre-operative weight loss on surgical outcomes and OR times after primary bariatric procedures, including…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Prevalence of Hyperparathyroidism, Mineral and Bone Disorders in Children with Advanced Chronic Kidney Disease by El Desoky, Sherif, Farag, Youssef MK, Safdar, Eatidal, Shalaby, Mohamed Ahmed, Singh, Ajay K., Kari, Jameela A.

    Published in Indian journal of pediatrics (01-05-2016)
    “…Objective To identify the prevalence and risk factors for secondary hyperparathyroidism in children with advanced stages of chronic kidney disease (CKD)…”
    Get full text
    Journal Article
  16. 16

    Kidney Health Initiative ESKD Data Standards Project by Dalrymple, Lorien S., Young, Eric W., Farag, Youssef MK, Fischer, Michael J., Hamilton, Emel, Hussein, Wael F., Lacson, Eduardo, Ofsthun, Norma J., Tentori, Francesca, West, Melissa

    Published in Kidney medicine (01-08-2022)
    “…The end-stage kidney disease (ESKD) Data Standards Project was launched by the Kidney Health Initiative (KHI) with the goal of standardizing dialysis-related…”
    Get full text
    Journal Article
  17. 17

    The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis by Whitlock, Reid, Leon, Silvia J, Manacsa, Hazel, Askin, Nicole, Rigatto, Claudio, Fatoba, Samuel T, Farag, Youssef M K, Tangri, Navdeep

    Published in Nephrology, dialysis, transplantation (31-10-2023)
    “…ABSTRACT Background and Objectives Dual renin-angiotensin-aldosterone system (RAAS) blockade involves dual therapy with a combination of angiotensin-converting…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Association of Bioimpedance Parameters with Increases in Blood Pressure during Hemodialysis by Elsayed, Enass, Farag, Youssef M K, Ravi, Katherine Scovner, Chertow, Glenn M, Mc Causland, Finnian R

    “…Intradialytic hypertension, defined as an increase in BP from pre- to post-hemodialysis (HD), affects 5%-15% of patients receiving maintenance HD and is…”
    Get more information
    Journal Article
  20. 20

    Clinical trial designs of emerging therapies for diabetic kidney disease (DKD) by Singh, Ajay K, Farag, Youssef M K, Zheng, Zihe, Bakris, George L

    Published in Postgraduate medicine (17-08-2024)
    “…Current evidence for medical therapies for diabetic kidney disease (DKD) is largely based on large-scale clinical trials. These trials, however, often exhibit…”
    Get full text
    Journal Article